Similarly, in ALL, JAK2 mutations are sometimes present alongside genetic alterations such as Philadelphia chromosome translocations or mutations in the BCR-ABL1 fusion gene, which are known to drive leukemogenesis. The gene discussed is JAK2; the disease is acute lymphoblastic leukemia.